SAGENT PHARMACEUTICALS has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan SAGENT PHARMACEUTICALS INC 401K PLAN
| Measure | Date | Value |
|---|
| 2023 : SAGENT PHARMACEUTICALS INC 401K PLAN 2023 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2023-12-31 | $0 |
| Total transfer of assets to this plan | 2023-12-31 | $0 |
| Total transfer of assets from this plan | 2023-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total income from all sources (including contributions) | 2023-12-31 | $7,649,311 |
| Total loss/gain on sale of assets | 2023-12-31 | $0 |
| Total of all expenses incurred | 2023-12-31 | $4,105,428 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-12-31 | $4,064,259 |
| Expenses. Certain deemed distributions of participant loans | 2023-12-31 | $9,847 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-12-31 | $3,323,505 |
| Value of total assets at end of year | 2023-12-31 | $27,893,350 |
| Value of total assets at beginning of year | 2023-12-31 | $24,349,467 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $31,322 |
| Total interest from all sources | 2023-12-31 | $18,528 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $675,718 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-12-31 | $675,718 |
| Was this plan covered by a fidelity bond | 2023-12-31 | Yes |
| Value of fidelity bond cover | 2023-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-12-31 | No |
| Contributions received from participants | 2023-12-31 | $2,397,688 |
| Participant contributions at end of year | 2023-12-31 | $216,097 |
| Participant contributions at beginning of year | 2023-12-31 | $187,999 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-12-31 | $180,700 |
| Other income not declared elsewhere | 2023-12-31 | $2,280 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Value of net income/loss | 2023-12-31 | $3,543,883 |
| Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $27,893,350 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $24,349,467 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-12-31 | No |
| Investment advisory and management fees | 2023-12-31 | $20,625 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-12-31 | $24,004,610 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-12-31 | $20,864,421 |
| Interest on participant loans | 2023-12-31 | $18,528 |
| Value of interest in common/collective trusts at end of year | 2023-12-31 | $3,672,643 |
| Value of interest in common/collective trusts at beginning of year | 2023-12-31 | $3,297,047 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-12-31 | $3,394,192 |
| Net investment gain or loss from common/collective trusts | 2023-12-31 | $235,088 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-12-31 | No |
| Contributions received in cash from employer | 2023-12-31 | $745,117 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-12-31 | $4,064,259 |
| Did the plan have assets held for investment | 2023-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-12-31 | Unqualified |
| Accountancy firm name | 2023-12-31 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2023-12-31 | 362887252 |
| Total unrealized appreciation/depreciation of assets | 2023-01-01 | $0 |
| Total transfer of assets to this plan | 2023-01-01 | $0 |
| Total transfer of assets from this plan | 2023-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $0 |
| Total income from all sources (including contributions) | 2023-01-01 | $7,649,311 |
| Total loss/gain on sale of assets | 2023-01-01 | $0 |
| Total of all expenses incurred | 2023-01-01 | $4,105,428 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-01-01 | $4,064,259 |
| Expenses. Certain deemed distributions of participant loans | 2023-01-01 | $9,847 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-01-01 | $3,323,505 |
| Value of total assets at end of year | 2023-01-01 | $27,893,350 |
| Value of total assets at beginning of year | 2023-01-01 | $24,349,467 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-01-01 | $31,322 |
| Total interest from all sources | 2023-01-01 | $18,528 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-01-01 | $675,718 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-01-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-01-01 | $675,718 |
| Was this plan covered by a fidelity bond | 2023-01-01 | Yes |
| Value of fidelity bond cover | 2023-01-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-01-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-01-01 | No |
| Contributions received from participants | 2023-01-01 | $2,397,688 |
| Participant contributions at end of year | 2023-01-01 | $216,097 |
| Participant contributions at beginning of year | 2023-01-01 | $187,999 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-01-01 | $180,700 |
| Other income not declared elsewhere | 2023-01-01 | $2,280 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-01-01 | No |
| Value of net income/loss | 2023-01-01 | $3,543,883 |
| Value of net assets at end of year (total assets less liabilities) | 2023-01-01 | $27,893,350 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-01-01 | $24,349,467 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-01-01 | No |
| Investment advisory and management fees | 2023-01-01 | $20,625 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-01-01 | $24,004,610 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-01-01 | $20,864,421 |
| Interest on participant loans | 2023-01-01 | $18,528 |
| Value of interest in common/collective trusts at end of year | 2023-01-01 | $3,672,643 |
| Value of interest in common/collective trusts at beginning of year | 2023-01-01 | $3,297,047 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-01-01 | $3,394,192 |
| Net investment gain or loss from common/collective trusts | 2023-01-01 | $235,088 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-01-01 | No |
| Contributions received in cash from employer | 2023-01-01 | $745,117 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-01-01 | $4,064,259 |
| Did the plan have assets held for investment | 2023-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-01-01 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-01-01 | 1 |
| Accountancy firm name | 2023-01-01 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2023-01-01 | 362887252 |
| 2022 : SAGENT PHARMACEUTICALS INC 401K PLAN 2022 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
| Total transfer of assets to this plan | 2022-12-31 | $0 |
| Total transfer of assets from this plan | 2022-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total income from all sources (including contributions) | 2022-12-31 | $-1,535,873 |
| Total loss/gain on sale of assets | 2022-12-31 | $0 |
| Total of all expenses incurred | 2022-12-31 | $4,193,026 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $4,083,273 |
| Expenses. Certain deemed distributions of participant loans | 2022-12-31 | $9,785 |
| Value of total corrective distributions | 2022-12-31 | $27,809 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $3,302,154 |
| Value of total assets at end of year | 2022-12-31 | $24,349,467 |
| Value of total assets at beginning of year | 2022-12-31 | $30,078,366 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $72,159 |
| Total interest from all sources | 2022-12-31 | $10,555 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $999,010 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $999,010 |
| Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
| Value of fidelity bond cover | 2022-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
| Contributions received from participants | 2022-12-31 | $2,324,989 |
| Participant contributions at end of year | 2022-12-31 | $187,999 |
| Participant contributions at beginning of year | 2022-12-31 | $170,477 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $215,964 |
| Other income not declared elsewhere | 2022-12-31 | $111 |
| Administrative expenses (other) incurred | 2022-12-31 | $72,159 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Value of net income/loss | 2022-12-31 | $-5,728,899 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $24,349,467 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $30,078,366 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $20,864,421 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $25,733,961 |
| Interest on participant loans | 2022-12-31 | $10,555 |
| Value of interest in common/collective trusts at end of year | 2022-12-31 | $3,297,047 |
| Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $4,173,928 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-5,697,066 |
| Net investment gain or loss from common/collective trusts | 2022-12-31 | $-150,637 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
| Contributions received in cash from employer | 2022-12-31 | $761,201 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $4,083,273 |
| Did the plan have assets held for investment | 2022-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
| Accountancy firm name | 2022-12-31 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2022-12-31 | 362887252 |
| Total unrealized appreciation/depreciation of assets | 2022-01-01 | $0 |
| Total transfer of assets to this plan | 2022-01-01 | $0 |
| Total transfer of assets from this plan | 2022-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total income from all sources (including contributions) | 2022-01-01 | $-1,535,873 |
| Total loss/gain on sale of assets | 2022-01-01 | $0 |
| Total of all expenses incurred | 2022-01-01 | $4,193,026 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-01-01 | $4,083,273 |
| Expenses. Certain deemed distributions of participant loans | 2022-01-01 | $9,785 |
| Value of total corrective distributions | 2022-01-01 | $27,809 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-01-01 | $3,302,154 |
| Value of total assets at end of year | 2022-01-01 | $24,349,467 |
| Value of total assets at beginning of year | 2022-01-01 | $30,078,366 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-01-01 | $72,159 |
| Total interest from all sources | 2022-01-01 | $10,555 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-01-01 | $999,010 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-01-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-01-01 | $999,010 |
| Was this plan covered by a fidelity bond | 2022-01-01 | Yes |
| Value of fidelity bond cover | 2022-01-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-01-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-01-01 | No |
| Contributions received from participants | 2022-01-01 | $2,324,989 |
| Participant contributions at end of year | 2022-01-01 | $187,999 |
| Participant contributions at beginning of year | 2022-01-01 | $170,477 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-01-01 | $215,964 |
| Other income not declared elsewhere | 2022-01-01 | $111 |
| Administrative expenses (other) incurred | 2022-01-01 | $72,159 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-01-01 | No |
| Value of net income/loss | 2022-01-01 | $-5,728,899 |
| Value of net assets at end of year (total assets less liabilities) | 2022-01-01 | $24,349,467 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-01-01 | $30,078,366 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-01-01 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-01-01 | $20,864,421 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-01-01 | $25,733,961 |
| Interest on participant loans | 2022-01-01 | $10,555 |
| Value of interest in common/collective trusts at end of year | 2022-01-01 | $3,297,047 |
| Value of interest in common/collective trusts at beginning of year | 2022-01-01 | $4,173,928 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-01-01 | $-5,697,066 |
| Net investment gain or loss from common/collective trusts | 2022-01-01 | $-150,637 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-01-01 | No |
| Contributions received in cash from employer | 2022-01-01 | $761,201 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-01-01 | $4,083,273 |
| Did the plan have assets held for investment | 2022-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-01-01 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-01-01 | 1 |
| Accountancy firm name | 2022-01-01 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2022-01-01 | 362887252 |
| 2021 : SAGENT PHARMACEUTICALS INC 401K PLAN 2021 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
| Total transfer of assets to this plan | 2021-12-31 | $0 |
| Total transfer of assets from this plan | 2021-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total income from all sources (including contributions) | 2021-12-31 | $8,950,606 |
| Total loss/gain on sale of assets | 2021-12-31 | $0 |
| Total of all expenses incurred | 2021-12-31 | $4,032,246 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $3,914,952 |
| Expenses. Certain deemed distributions of participant loans | 2021-12-31 | $53,543 |
| Value of total corrective distributions | 2021-12-31 | $71 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $4,773,728 |
| Value of total assets at end of year | 2021-12-31 | $30,078,366 |
| Value of total assets at beginning of year | 2021-12-31 | $25,160,006 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $63,680 |
| Total interest from all sources | 2021-12-31 | $17,402 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $1,288,784 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $1,288,784 |
| Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
| Value of fidelity bond cover | 2021-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
| Contributions received from participants | 2021-12-31 | $2,498,153 |
| Participant contributions at end of year | 2021-12-31 | $170,477 |
| Participant contributions at beginning of year | 2021-12-31 | $303,377 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $1,409,695 |
| Other income not declared elsewhere | 2021-12-31 | $17,977 |
| Administrative expenses (other) incurred | 2021-12-31 | $63,680 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Value of net income/loss | 2021-12-31 | $4,918,360 |
| Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $30,078,366 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $25,160,006 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $25,733,961 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $23,513,942 |
| Interest on participant loans | 2021-12-31 | $17,402 |
| Value of interest in common/collective trusts at end of year | 2021-12-31 | $4,173,928 |
| Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $1,342,687 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $2,634,187 |
| Net investment gain or loss from common/collective trusts | 2021-12-31 | $218,528 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
| Contributions received in cash from employer | 2021-12-31 | $865,880 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $3,914,952 |
| Did the plan have assets held for investment | 2021-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
| Accountancy firm name | 2021-12-31 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2021-12-31 | 362887252 |
| 2020 : SAGENT PHARMACEUTICALS INC 401K PLAN 2020 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
| Total transfer of assets to this plan | 2020-12-31 | $87,085 |
| Total transfer of assets from this plan | 2020-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total income from all sources (including contributions) | 2020-12-31 | $8,716,719 |
| Total loss/gain on sale of assets | 2020-12-31 | $0 |
| Total of all expenses incurred | 2020-12-31 | $2,434,160 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $2,430,135 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $4,769,893 |
| Value of total assets at end of year | 2020-12-31 | $25,160,006 |
| Value of total assets at beginning of year | 2020-12-31 | $18,790,362 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $4,025 |
| Total interest from all sources | 2020-12-31 | $18,134 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $793,581 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $793,581 |
| Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
| Value of fidelity bond cover | 2020-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
| Contributions received from participants | 2020-12-31 | $2,283,137 |
| Participant contributions at end of year | 2020-12-31 | $303,377 |
| Participant contributions at beginning of year | 2020-12-31 | $149,719 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $1,732,874 |
| Other income not declared elsewhere | 2020-12-31 | $263,245 |
| Administrative expenses (other) incurred | 2020-12-31 | $4,025 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Value of net income/loss | 2020-12-31 | $6,282,559 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $25,160,006 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $18,790,362 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $23,513,942 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $17,292,417 |
| Interest on participant loans | 2020-12-31 | $18,134 |
| Value of interest in common/collective trusts at end of year | 2020-12-31 | $1,342,687 |
| Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $1,348,226 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $2,836,800 |
| Net investment gain or loss from common/collective trusts | 2020-12-31 | $35,066 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
| Contributions received in cash from employer | 2020-12-31 | $753,882 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $2,430,135 |
| Did the plan have assets held for investment | 2020-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
| Accountancy firm name | 2020-12-31 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2020-12-31 | 362887252 |
| 2019 : SAGENT PHARMACEUTICALS INC 401K PLAN 2019 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
| Total transfer of assets to this plan | 2019-12-31 | $0 |
| Total transfer of assets to this plan | 2019-12-31 | $0 |
| Total transfer of assets from this plan | 2019-12-31 | $0 |
| Total transfer of assets from this plan | 2019-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total income from all sources (including contributions) | 2019-12-31 | $5,999,889 |
| Total income from all sources (including contributions) | 2019-12-31 | $5,999,889 |
| Total loss/gain on sale of assets | 2019-12-31 | $0 |
| Total loss/gain on sale of assets | 2019-12-31 | $0 |
| Total of all expenses incurred | 2019-12-31 | $1,238,935 |
| Total of all expenses incurred | 2019-12-31 | $1,238,935 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $1,223,920 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $1,223,920 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $2,472,559 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $2,472,559 |
| Value of total assets at end of year | 2019-12-31 | $18,790,362 |
| Value of total assets at end of year | 2019-12-31 | $18,790,362 |
| Value of total assets at beginning of year | 2019-12-31 | $14,029,408 |
| Value of total assets at beginning of year | 2019-12-31 | $14,029,408 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $15,015 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $15,015 |
| Total interest from all sources | 2019-12-31 | $8,372 |
| Total interest from all sources | 2019-12-31 | $8,372 |
| Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $661,822 |
| Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $661,822 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $661,822 |
| Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $661,822 |
| Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
| Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
| Value of fidelity bond cover | 2019-12-31 | $500,000 |
| Value of fidelity bond cover | 2019-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
| If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2019-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
| Contributions received from participants | 2019-12-31 | $1,747,322 |
| Contributions received from participants | 2019-12-31 | $1,747,322 |
| Participant contributions at end of year | 2019-12-31 | $149,719 |
| Participant contributions at end of year | 2019-12-31 | $149,719 |
| Participant contributions at beginning of year | 2019-12-31 | $132,879 |
| Participant contributions at beginning of year | 2019-12-31 | $132,879 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $115,073 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $115,073 |
| Other income not declared elsewhere | 2019-12-31 | $31,335 |
| Other income not declared elsewhere | 2019-12-31 | $31,335 |
| Administrative expenses (other) incurred | 2019-12-31 | $15,015 |
| Administrative expenses (other) incurred | 2019-12-31 | $15,015 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Value of net income/loss | 2019-12-31 | $4,760,954 |
| Value of net income/loss | 2019-12-31 | $4,760,954 |
| Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $18,790,362 |
| Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $18,790,362 |
| Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $14,029,408 |
| Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $14,029,408 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $17,292,417 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $17,292,417 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $12,757,622 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $12,757,622 |
| Interest on participant loans | 2019-12-31 | $8,372 |
| Interest on participant loans | 2019-12-31 | $8,372 |
| Value of interest in common/collective trusts at end of year | 2019-12-31 | $1,348,226 |
| Value of interest in common/collective trusts at end of year | 2019-12-31 | $1,348,226 |
| Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $1,138,907 |
| Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $1,138,907 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $2,792,428 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $2,792,428 |
| Net investment gain or loss from common/collective trusts | 2019-12-31 | $33,373 |
| Net investment gain or loss from common/collective trusts | 2019-12-31 | $33,373 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
| Contributions received in cash from employer | 2019-12-31 | $610,164 |
| Contributions received in cash from employer | 2019-12-31 | $610,164 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $1,223,920 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $1,223,920 |
| Did the plan have assets held for investment | 2019-12-31 | Yes |
| Did the plan have assets held for investment | 2019-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
| Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
| Accountancy firm name | 2019-12-31 | CUTRARA & COMPANY |
| Accountancy firm name | 2019-12-31 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2019-12-31 | 362887252 |
| Accountancy firm EIN | 2019-12-31 | 362887252 |
| 2018 : SAGENT PHARMACEUTICALS INC 401K PLAN 2018 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2018-12-31 | $0 |
| Total transfer of assets to this plan | 2018-12-31 | $0 |
| Total transfer of assets from this plan | 2018-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
| Total income from all sources (including contributions) | 2018-12-31 | $1,371,561 |
| Total loss/gain on sale of assets | 2018-12-31 | $0 |
| Total of all expenses incurred | 2018-12-31 | $1,932,963 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $1,906,693 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $2,287,555 |
| Value of total assets at end of year | 2018-12-31 | $14,029,408 |
| Value of total assets at beginning of year | 2018-12-31 | $14,590,810 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $26,270 |
| Total interest from all sources | 2018-12-31 | $8,290 |
| Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $765,070 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $765,070 |
| Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
| Value of fidelity bond cover | 2018-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2018-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
| Contributions received from participants | 2018-12-31 | $1,579,252 |
| Participant contributions at end of year | 2018-12-31 | $132,879 |
| Participant contributions at beginning of year | 2018-12-31 | $142,096 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2018-12-31 | $139,000 |
| Other income not declared elsewhere | 2018-12-31 | $28,221 |
| Administrative expenses (other) incurred | 2018-12-31 | $26,270 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
| Value of net income/loss | 2018-12-31 | $-561,402 |
| Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $14,029,408 |
| Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $14,590,810 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $12,757,622 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $13,555,813 |
| Interest on participant loans | 2018-12-31 | $8,290 |
| Value of interest in common/collective trusts at end of year | 2018-12-31 | $1,138,907 |
| Value of interest in common/collective trusts at beginning of year | 2018-12-31 | $892,901 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-1,744,191 |
| Net investment gain or loss from common/collective trusts | 2018-12-31 | $26,616 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
| Contributions received in cash from employer | 2018-12-31 | $569,303 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $1,906,693 |
| Did the plan have assets held for investment | 2018-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
| Accountancy firm name | 2018-12-31 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2018-12-31 | 362887252 |
| 2017 : SAGENT PHARMACEUTICALS INC 401K PLAN 2017 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2017-12-31 | $0 |
| Total transfer of assets to this plan | 2017-12-31 | $0 |
| Total transfer of assets from this plan | 2017-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
| Total income from all sources (including contributions) | 2017-12-31 | $4,190,899 |
| Total loss/gain on sale of assets | 2017-12-31 | $0 |
| Total of all expenses incurred | 2017-12-31 | $2,230,889 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $2,216,389 |
| Expenses. Certain deemed distributions of participant loans | 2017-12-31 | $10,741 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $1,884,518 |
| Value of total assets at end of year | 2017-12-31 | $14,590,810 |
| Value of total assets at beginning of year | 2017-12-31 | $12,630,800 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $3,759 |
| Total interest from all sources | 2017-12-31 | $6,862 |
| Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $482,382 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $482,382 |
| Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
| Value of fidelity bond cover | 2017-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2017-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
| Contributions received from participants | 2017-12-31 | $1,372,817 |
| Participant contributions at end of year | 2017-12-31 | $142,096 |
| Participant contributions at beginning of year | 2017-12-31 | $216,368 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2017-12-31 | $51,258 |
| Other income not declared elsewhere | 2017-12-31 | $15,591 |
| Administrative expenses (other) incurred | 2017-12-31 | $3,759 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
| Value of net income/loss | 2017-12-31 | $1,960,010 |
| Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $14,590,810 |
| Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $12,630,800 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $13,555,813 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $11,380,671 |
| Interest on participant loans | 2017-12-31 | $6,862 |
| Value of interest in common/collective trusts at end of year | 2017-12-31 | $892,901 |
| Value of interest in common/collective trusts at beginning of year | 2017-12-31 | $1,033,761 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $1,776,718 |
| Net investment gain or loss from common/collective trusts | 2017-12-31 | $24,828 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
| Contributions received in cash from employer | 2017-12-31 | $460,443 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $2,216,389 |
| Did the plan have assets held for investment | 2017-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
| Accountancy firm name | 2017-12-31 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2017-12-31 | 362887252 |
| 2016 : SAGENT PHARMACEUTICALS INC 401K PLAN 2016 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2016-12-31 | $0 |
| Total transfer of assets to this plan | 2016-12-31 | $0 |
| Total transfer of assets from this plan | 2016-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
| Total income from all sources (including contributions) | 2016-12-31 | $2,796,725 |
| Total loss/gain on sale of assets | 2016-12-31 | $0 |
| Total of all expenses incurred | 2016-12-31 | $2,742,770 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $2,678,861 |
| Expenses. Certain deemed distributions of participant loans | 2016-12-31 | $672 |
| Value of total corrective distributions | 2016-12-31 | $61,662 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $1,967,632 |
| Value of total assets at end of year | 2016-12-31 | $12,630,800 |
| Value of total assets at beginning of year | 2016-12-31 | $12,576,845 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $1,575 |
| Total interest from all sources | 2016-12-31 | $10,162 |
| Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $323,089 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2016-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2016-12-31 | $323,089 |
| Was this plan covered by a fidelity bond | 2016-12-31 | Yes |
| Value of fidelity bond cover | 2016-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2016-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2016-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
| Contributions received from participants | 2016-12-31 | $1,404,581 |
| Participant contributions at end of year | 2016-12-31 | $216,368 |
| Participant contributions at beginning of year | 2016-12-31 | $203,209 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2016-12-31 | $92,147 |
| Administrative expenses (other) incurred | 2016-12-31 | $1,575 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
| Value of net income/loss | 2016-12-31 | $53,955 |
| Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $12,630,800 |
| Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $12,576,845 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2016-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-12-31 | $11,380,671 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2016-12-31 | $11,589,728 |
| Interest on participant loans | 2016-12-31 | $10,162 |
| Value of interest in common/collective trusts at end of year | 2016-12-31 | $1,033,761 |
| Value of interest in common/collective trusts at beginning of year | 2016-12-31 | $783,908 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-12-31 | $468,699 |
| Net investment gain or loss from common/collective trusts | 2016-12-31 | $27,143 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2016-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2016-12-31 | No |
| Contributions received in cash from employer | 2016-12-31 | $470,904 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2016-12-31 | $2,678,861 |
| Did the plan have assets held for investment | 2016-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2016-12-31 | No |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2016-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2016-12-31 | Disclaimer |
| Accountancy firm name | 2016-12-31 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2016-12-31 | 362887252 |
| 2015 : SAGENT PHARMACEUTICALS INC 401K PLAN 2015 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2015-12-31 | $0 |
| Total transfer of assets from this plan | 2015-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
| Total income from all sources (including contributions) | 2015-12-31 | $1,727,600 |
| Total loss/gain on sale of assets | 2015-12-31 | $0 |
| Total of all expenses incurred | 2015-12-31 | $1,773,100 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $1,755,018 |
| Expenses. Certain deemed distributions of participant loans | 2015-12-31 | $16,082 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $1,855,190 |
| Value of total assets at end of year | 2015-12-31 | $12,576,845 |
| Value of total assets at beginning of year | 2015-12-31 | $12,622,345 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-12-31 | $2,000 |
| Total interest from all sources | 2015-12-31 | $9,076 |
| Total dividends received (eg from common stock, registered investment company shares) | 2015-12-31 | $468,623 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2015-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2015-12-31 | $468,623 |
| Was this plan covered by a fidelity bond | 2015-12-31 | Yes |
| Value of fidelity bond cover | 2015-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2015-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2015-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2015-12-31 | No |
| Contributions received from participants | 2015-12-31 | $1,440,060 |
| Participant contributions at end of year | 2015-12-31 | $203,209 |
| Participant contributions at beginning of year | 2015-12-31 | $151,012 |
| Administrative expenses (other) incurred | 2015-12-31 | $2,000 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
| Value of net income/loss | 2015-12-31 | $-45,500 |
| Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $12,576,845 |
| Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $12,622,345 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2015-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2015-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2015-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2015-12-31 | $11,589,728 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2015-12-31 | $12,471,333 |
| Interest on participant loans | 2015-12-31 | $9,076 |
| Value of interest in common/collective trusts at end of year | 2015-12-31 | $783,908 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2015-12-31 | $-606,136 |
| Net investment gain or loss from common/collective trusts | 2015-12-31 | $847 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2015-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2015-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2015-12-31 | No |
| Contributions received in cash from employer | 2015-12-31 | $415,130 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2015-12-31 | $1,755,018 |
| Did the plan have assets held for investment | 2015-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2015-12-31 | No |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2015-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2015-12-31 | Disclaimer |
| Accountancy firm name | 2015-12-31 | CUTRARA & COMPANY |
| Accountancy firm EIN | 2015-12-31 | 362887252 |
| 2009 : SAGENT PHARMACEUTICALS INC 401K PLAN 2009 401k financial data |
|---|
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2009-12-31 | $0 |
